𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase 3 trial of everolimus for metastatic renal cell carcinoma : Final results and analysis of prognostic factors

✍ Scribed by Robert J. Motzer; Bernard Escudier; Stephane Oudard; Thomas E. Hutson; Camillo Porta; Sergio Bracarda; Viktor Grünwald; John A. Thompson; Robert A. Figlin; Norbert Hollaender; Andrea Kay; Alain Ravaud; for the RECORD-1 Study Group

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
426 KB
Volume
116
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Granulocyte-macrophage–colony stimulatin
Granulocyte-macrophage–colony stimulating factor in combination immunotherapy for patients with metastatic renal cell carcinoma : Results of two Phase II clinical trials
✍ Christopher W. Ryan; Nicholas J. Vogelzang; Mary C. Dumas; Timothy Kuzel; Walter 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

The aim of this study was to determine the response rates and toxicity of two regimens containing granulocyte-macrophage-colony stimulating factor (GM-CSF) in combination with interleukin-2 (IL-2) in the treatment of patients with metastatic renal cell carcinoma. ## METHODS. Therapy given in the f

Phase II trial of 5-fluorouracil, interf
Phase II trial of 5-fluorouracil, interferon-α and continuous infusion interleukin-2 for patients with metastatic renal cell carcinoma
✍ Julie A. Ellerhorst; Avishay Sella; Robert J. Amato; Shi-Ming Tu; Randall E. Mil 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

## RESULTS. Fifty-five patients were enrolled in the trial and 52 were evaluable for ogy, The University of Texas M. D. Anderson response. All patients experienced fever and flu-like symptoms. Grade 3 or 4 nonhe-Cancer Center, Houston, Texas. matologic toxic effects included hypertension (48%), d

External validation of IMP3 expression a
External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma
✍ Nathan E. Hoffmann; Yuri Sheinin; Christine M. Lohse; Alexander S. Parker; Bradl 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 1 views

## Abstract ## BACKGROUND High‐quality external validation studies have recently been highlighted to be of paramount importance for proper translation of prognostic markers into the clinical setting. To that end, the authors examined associations of the insulin‐like growth factor‐II mRNA binding p